| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $170,621 ) |
| 2023 | 2019 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R44AG059371 | A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA | 000 | 3 | NIH | 5/26/2023 | $170,621 |
|
| Issue Date FY: 2019 ( Subtotal = $513,446 ) |
| 2019 | 2019 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R44AG059371 | A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA | 002 | 3 | NIH | 8/13/2019 | -$374,928 |
| 2019 | 2019 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R44AG059371 | A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA | 001 | 3 | NIH | 11/9/2018 | $987,193 |
| 2019 | 2018 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R44AG059371 | A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA | 000 | 2 | NIH | 10/27/2018 | $0 |
| 2019 | 2017 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R44AI112124 | Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine | 000 | 4 | NIH | 7/12/2019 | -$98,819 |
|
| Issue Date FY: 2018 ( Subtotal = $986,704 ) |
| 2018 | 2018 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R44AG059371 | A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA | 000 | 2 | NIH | 1/9/2018 | $986,704 |
| 2018 | 2018 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R44AG059371 | A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA | 001 | 2 | NIH | 2/9/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $749,718 ) |
| 2017 | 2017 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R44AI112124 | Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine | 000 | 4 | NIH | 6/16/2017 | $749,718 |
| 2017 | 2015 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R44AI091507 | Conformational Stabilization of the HIV-1 Env Trimer | 000 | 5 | NIH | 2/17/2017 | $0 |
| 2017 | 2015 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R43AI112124 | Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine | 000 | 2 | NIH | 6/13/2017 | $0 |
| 2017 | 2015 | AVATAR MEDICAL, LLC | 140 58TH ST BLDG A STE 8J | BROOKLYN | NY | 11220-2539 | KINGS | USA | R43AI118087 | A Universal Flu Vaccine Based on Conformationally Locked Soluble Headless HA | 000 | 1 | NIH | 6/12/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $749,449 ) |
| 2016 | 2016 | AVATAR MEDICAL LLC | 426 2ND STREET | BROOKLYN | NY | 11215 | KINGS | USA | R44AI112124 | Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine | 000 | 3 | NIH | 7/1/2016 | $749,449 |
|
| Issue Date FY: 2015 ( Subtotal = $1,521,369 ) |
| 2015 | 2015 | AVATAR MEDICAL LLC | 426 2ND STREET | BROOKLYN | NY | 11215 | KINGS | USA | R43AI118087 | A Universal Flu Vaccine Based on Conformationally Locked Soluble Headless HA | 001 | 1 | NIH | 7/22/2015 | -$224,905 |
| 2015 | 2015 | AVATAR MEDICAL LLC | 426 2ND STREET | BROOKLYN | NY | 11215 | KINGS | USA | R44AI091507 | Conformational Stabilization of the HIV-1 Env Trimer | 000 | 5 | NIH | 8/7/2015 | $999,646 |
| 2015 | 2015 | AVATAR MEDICAL LLC | 426 2ND STREET | BROOKLYN | NY | 11215 | KINGS | USA | R43AI112124 | Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine | 000 | 2 | NIH | 4/28/2015 | $296,818 |
| 2015 | 2015 | AVATAR MEDICAL LLC | 426 2ND STREET | BROOKLYN | NY | 11215 | KINGS | USA | R43AI118087 | A Universal Flu Vaccine Based on Conformationally Locked Soluble Headless HA | 000 | 1 | NIH | 2/3/2015 | $224,905 |
| 2015 | 2015 | AVATAR MEDICAL LLC | 426 2ND STREET | BROOKLYN | NY | 11215 | KINGS | USA | R43AI118087 | A Universal Flu Vaccine Based on Conformationally Locked Soluble Headless HA | 001 | 1 | NIH | 7/22/2015 | $224,905 |
|
| Issue Date FY: 2014 ( Subtotal = $1,292,515 ) |
| 2014 | 2014 | AVATAR MEDICAL LLC | 426 2ND STREET | BROOKLYN | NY | 11215 | KINGS | USA | R43AI112124 | Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine | 000 | 1 | NIH | 5/26/2014 | $298,852 |
| 2014 | 2014 | AVATAR MEDICAL LLC | 426 2ND STREET | BROOKLYN | NY | 11215 | KINGS | USA | R44AI091507 | Conformational Stabilization of the HIV-1 Env Trimer | 000 | 4 | NIH | 7/24/2014 | $993,663 |
|
| Issue Date FY: 2013 ( Subtotal = $1,005,633 ) |
| 2013 | 2013 | AVATAR MEDICAL LLC | 240 DR MLK, JR BLVD | NEWARK | NJ | 07102 | ESSEX | USA | R44AI091507 | Conformational Stabilization of the HIV-1 Env Trimer | 000 | 3 | NIH | 6/15/2013 | $999,641 |
| 2013 | 2012 | AVATAR MEDICAL LLC | 240 DR MLK, JR BLVD | NEWARK | NJ | 07102 | ESSEX | USA | R43AI091507 | CONFORMATIONAL STABILIZATION OF THE HIV-1 ENV TRIMER | 000 | 2 | NIH | 7/16/2013 | $5,992 |
|
| Issue Date FY: 2012 ( Subtotal = $293,607 ) |
| 2012 | 2012 | AVATAR MEDICAL LLC | 240 DR MLK, JR BLVD | NEWARK | NJ | 07102 | ESSEX | USA | R43AI091507 | CONFORMATIONAL STABILIZATION OF THE HIV-1 ENV TRIMER | 000 | 2 | NIH | 8/15/2012 | $293,607 |
|
| Issue Date FY: 2011 ( Subtotal = $297,583 ) |
| 2011 | 2011 | AVATAR MEDICAL LLC | 240 DR MLK, JR BLVD | NEWARK | NJ | 07102 | ESSEX | USA | R43AI091507 | CONFORMATIONAL STABILIZATION OF THE HIV-1 ENV TRIMER | 000 | 1 | NIH | 8/16/2011 | $297,583 |
|
| Issue Date FY: 2002 ( Subtotal = $99,900 ) |
| 2002 | 2002 | AVATAR BIOTECHNOLOGIES INC | | | | | | | R43GM065676 | NOVEL LITHOGRAPHIC PROTEIN-BIORECEPTOR IMMOBILIZATION | 000 | 1 | NIH | 6/14/2002 | $99,900 |
|
|